Abstract
The assays for angiogenesis in current use include the corneal micropocket technique (Gimbrone et al., 1974; Leibovich et al., 1987), chick embryo chorioallantoic membrane (Auerbach et al., 1974; Crum et al., 1985), the hamster cheek pouch (Greenblatt & Shubik,1968; Schrieber et al., 1986), and rat dorsal air sac (Folkman et al., 1971; Ingber et al., 1990). The development of these methods in the 1970s was instrumental in the discovery, purification and biochemical characterisation of angiogenic factors and inhibitors. However, these models, with the exception of the corneal assay, are only qualitative or semi-quantitative. Thus Vallee et al. (1985) concluded that “none of the procedures available for studying angiogenesis is ideal and that the design and verification of specific and reproducible methodology remains an imperative of the highest priority”. In the last five years, several new models have been developed, e.g. subcutaneous implantation of plastic chambers (Dvorak et al., 1987) or porous polytetrafluoroethylene tubes (Sprugel et al., 1987). In addition, techniques involving the subcutaneous implantation of sterile sponges into experimental animals have become popular (Davidson et al., 1985; Fajardo et al., 1988; Kusaka et al., 1991).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrade, S.P., Fan, T.-P.D., and Lewis, G.P., 1987, Quantitative in-vivo studies on angiogenesis in a rat sponge model, Br. J. exp. Path., 68:755.
Auerbach, R., Kubai, L., Knighton, D., and Folkman, J., 1974, A simple procedure for the long term cultivation of chicken embryos. Dev. Biol. 41:391–394.
Broadley, K.N., Aquino, A.M., Woodward, S.C., Buckley-Sturrock, A., Sato, Y., Rifkin, D.B., and Davidson, J.M., 1989, Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair, Lab. Invest., 61:571–575.
Buckley, A., Davidson, J.M., Kamerath, C.D., and Woodword, S.C., 1987, Epidermal growth factor increases granulation tissue formation dose dependently, J. Surg. Res., 43:322–328.
Buckley, A., Davidson, J.M., Kamerath, C.D., Wolt, T.B., and Woodword, S.C., 1985, Sustained release of epidermal growth factor accelerates wound repair, Proc. Natl. Acad. Sci., USA; 82:7340–7344.
Ciomei, M., Pesenti, E., Sola, F., Pastori, W., Mariani, M., Grandi, M., and Spreafico, F., 1991, Antagonistic effect of suramin on bFGF: in vitro and in vivo results, Int. J. Radiat. 60:78.
Crum, R., Szabo, S., and Folkman, J., 1985, A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment, Science, 230:1375–1378.
Davidson, J.M., Klagsbrun, M., Hill, K.E., Buckley, A., Sullivan, R., Brewer, P.A., and Woodward, S.C., 1985, Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor, J. Cell Biol., 100:1219.
Dvorak, H.F., Harvey, V.S., Estrella, P., Brown, L.F., McDonagh, J., and Dvorak, A.M., 1987, Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing, Lab. Invest., 57:673–686.
Fajardo, L.F., Kowalski, J., Kwan, H.H., Prionas, S.D., and Allison, A.C., 1988, The disc angiogenesis system, Lab. Invest., 58:718–724.
Fan, T.-P.D., and Hu, D.-E., 1991, Modulation of angiogenesis by inflammatory polypeptides, Int. J. Radiat. Biol., 60:71.
Fan, T.-P.D., Hu, D.E., Smither, R.L. and Gresham, G.A., (in press) Further studies on angiogenesis in a rat sponge model, in: “Angiogenesis,” P.B. Weisz., R. Langer and R. Steiner, ed., Karger AG, Basel, New York and Tokyo.
Fernandez, L.A., Twickler, J. and Mead, A., 1985, Neovascularization produced by angiotensin II J. Lab. Clin. Med., 105:141–146
Folkman, J., Merler, E., Abernathy, C., and Williams, G., 1971, Isolation of a tumor factor responsible for angiogenesis, J. Exp. Med. 133:275–288.
Ford, H.R., Hoffman, R.A., Wing, E.J., Magee, D.M., McIntyre, L.A., and Simmons, R.L., 1989, Characterization of wound cytokines in the sponge matrix model, Arch. Surg., 124:1422–1428.
Ford, H.R., Hoffman, R.A., Wing, E.J., Magee, D.M., McIntyre, L.A., and Simmons, R.L., 1990, Tumor necrosis factor, macrophage colony-stimulating factor, and interleukin 1 production within sponge matrix allografts, Transplantation, 50:460–466.
Gimbrone, M.A. Jr., Cotran, R.S., Leapman, S.B., and Folkman, J., 1974, Growth and neovascularisation: an experimental model using the rabbit cornea, J. Natl. Cancer Inst., 52:413–427.
Greenblatt, M., and Shubik, P., 1968, Tumor angiogenesis; transfilter diffusion studies in the hamster by the transparent chamber technique, J. Natl. Cancer Inst., 41:111–124.
Haegerstrand, A., Dalsgaard, C.-J., Jonzon, B., Larsson, O. and Nilsson, J., 1990, Calcitonin gene-related peptide stimulates proliferation of human endothelial cells, Proc. Natl. Acad. Sci. USA, 87:3299–3303.
Haynes, W.L., Proia, A.D. and Klintworth, G.K., 1989, Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat, Invest. Ophthalmol. Vis.Sci., 30:1588–1593.
Hiley, C.R., Yates, M.S., Roberts, P.J., and Bloom, A.E., 1980, Alterations in liver blood flow during glycerol-induced acute renal failure in the rat, Nephron, 26:244–248.
Hu, D.E., and Fan, T.-P.D., 1991, Synergistic interaction between bradykinin and interleukin 1 in angiogenesis, Br. J. Pharmacol., 104:83P.
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J., 1990, Synthetic analogues of fumagillin that inhibit angiogenesis and tumor growth, Nature, 348:555–557.
Kimball, E.S., and Fisher, M.C., 1988, Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by neuropeptides, J. Immunol., 141:4203–4208
Kurkinen, M., Vaheri, A., Roberts, P.J., and Stenman, S., 1980, Sequential appearance of fibronectin and collagen in experimental granulation tissue, Lab. Invest., 43:47–51.
Kusaka, M., Sudo, K., Fujita, T., Marui, S., Itoh, F., Ingber, D., and Folkman, J., 1991, Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent, Biochem. Biophys. Res. Comm., 174:1070–1076.
Le Noble, F.A.C., Hekking, J.W.N., Van Straaten, H.W.M., Slaaf, D.W. and Struyker Bouclier, H.A.J., 1991, Angiotensin Il stimulates angiogenesis in the chorioallantoic membrane of the chicken embryo, Eur. J. Pharmacol., 195:305–306.
Leibovich, S.J., Polverini, P.J., Shepard, H.M., Wiseman, D.M., Shively, V., and Nuseir, N., 1987, Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha, Nature, 329:630–632.
Mahadevan, V., Hart, I.R., and Lewis, G.P., 1989, Factors influencing blood supply in wound granuloma quantitated by a new in vivo technique, Cancer Res., 49:415–419.
Mahadevan, V., Malik, S.T.A., Meager, A., Fiers, W., Lewis, G.P., and Hart, I.R., 1990, Role of tumour necrosis factor in flavone acetic acid induced tumour vasculature shutdown, Cancer Res., 50:5537–5542.
Maragoudakis, M.E Sarmonika, M., and Panoustacopoulou, M., 1988, Inhibition of basement membrane biosynthesis prevents angiogenesis, J. Pharmacol. Exp. Ther., 244:729–733
McDevitt, D.G., and Nies, A.S., 1976, Simultaneous measurements of cardiac output and its distribution with microspheres in the rat, Cardiovasc. Res., 10:494–498.
Motro, B., Itin, A., Sachs, L., Keshet, E., 1990, Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci.. USA, 87:3092–3096.
Parnham, M.J., De Leve, L.D., and Saxena, P.R., 1979, Development of enhanced blood flow responses to prostaglandin E1 in carrageenaninduced granulation tissue, Agents and Actions, 9:510–515.
Plunkett, M.L., and Hailey, J.A., 1990, An in vivo quantitative angiogenesis model using tumour cells entrapped alginate, Lab. Invest., 62:510–517.
Presta, M., Rusnati, M., Statuto, M., Maier, J.A.M., Gualandris, A., Pozzi, A., and Ragnotti, R., 1991, Basic fibroblast growth factor (bFGF) and endothelial cells: receptor interactions, signal transduction, and cellular response. This issue.
Richardson, T.C., Humphreys, J.A.H., and Townsend, K.M.S., 1987, Subcutaneous implantation of double velour Dacron into the mouse: infiltration and angiogenesis, Br. J.exp. Path., 68:359–366.
Robertson, N.E., Discafani, C.M., Downs, E.C., Halley, J.A., Sarre, O., Runkle, R.L.Jr., Popper, T.L., and Plunkett, M.L., 1991, A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis, Cancer Res., 51:1339–1344.
Schreiber, A.B., Winkler, M.E., and Derynck, D., 1986, Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor, Science 232:1250–1253.
Smaje, L.H., Noor, N.M., and Clough, G.F., 1988, Changing sensitivity to H1 and H2 receptor agonists in the growing vasculature, in: “Vascular Endotheium in Health and Disease,” Shu Chien, ed., Advances in Experimental Medicine and Biology, Plenum, New York. vol 242, pp 145–150.
Smither, R.L., and Fan, T.-P.D., 1990, PAF antagonists inhibit angiogenesis in a rat sponge model, Br. J. Pharmacol., 99:87P.
Smither, R.L., and Fan, T.-P.D., 1991, Role of arachidonic acid metabolites in a rat sponge model of angiogenesis, Int. J. Radiat. Biol., 60:48.
Sprugel, K.H., McPherson, J.M., Clowes, A.W., and Ross, R., 1987, Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers, Am. J. Pathol.. 129:601–613.
Takagi, Y., Fukase, M., Takata, S., Yoshimi, H., Tokunaga, O., and Fujita, T., 1990, Autocrine effect of endothelin on DNA synthesis in human vascular endothelial cells, Biochem. Biophys. Res. Comm., 168:537–543.
Thompson, J.A., Anderson, K.D., DiPietro, J.M., Zweibel, J.A., Zametta, M., Anderson, W.F., and Maciag, T., 1988, Site-directed neovessel formation in vivo, Science, 241:1349–1352.
Thompson, W.D., and Brown, F.I., 1987, Quantitation of histamine-induced angiogenesis in the chick chorioallantoic membrane: mode of action of histamine is indirect, Int. J. Microcir. Clin. Exp., 6:343–357.
Thorpe, P.E., Wallace, P.M., Knyba, R.E., Watson, G.J., Mahadevan, V.A., Land, H., Yerganian, G., and Brown, P.J., 1991, Selective killing of proliferating endothelial cells by an anti-fibronectin receptor immunotoxin, Int. J. Radial. Biol., 60:24.
Vallee, B.L., Riordan, J.F., Lobb, R.R., Higachi, N., Fett, J.W., Crossley, G., Buhler, R., Budzik, G., Breddam, K., Bethune, J.L., and Alderman, E.M., 1985, Tumor-derived angiogenesis factors from rat Walker 256 carcinoma: an experimental investigation and review, Experientia,41:1–15.
Wang, D.H., and Prewitt, R.L., 1990, Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats, Hypertension, 15:68–77
West, D.C., Hampson, I.N., Arnold, F., and Kumar, S., 1985, Angiogenesisinduced by degradation products of hyaluronic acid, Science, 228:1324–1326.
Woll, P.J., and Rozengurt, E., 1989, Neuropeptides as growth regulators. Br. Med. Bull., 45:492–505.
Ziche, M., Morbidelli, L., Pacini, M., Geppetti, P., Alessandri, G. and Maggi, C.A., 1990, Substance P stimulates neovascularisation in vivo and proliferation of cultured endothelial cells, Microvasc. Res., 40:264–278.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fan, TP.D., Hu, DE., Hiley, C.R. (1992). Development and Validation of a Sponge Model for Quantitative Studies on Angiogenesis. In: Maragoudakis, M.E., Gullino, P., Lelkes, P.I. (eds) Angiogenesis in Health and Disease. NATO ASI Series, vol 227. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3358-0_30
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3358-0_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6481-8
Online ISBN: 978-1-4615-3358-0
eBook Packages: Springer Book Archive